Development of a buccal bioadhesive nicotine tablet formulation for smoking cessation

被引:50
|
作者
Ikinci, G
Senel, S [1 ]
Wilson, CG
Sumnu, M
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, TR-06100 Ankara, Turkey
[2] Univ Strathclyde, SIBS, Dept Pharmaceut Sci, Glasgow G4 0NR, Lanark, Scotland
关键词
nicotine hydrogen tartrate; buccal tablets; bioadhesion;
D O I
10.1016/j.ijpharm.2003.10.040
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Bioadhesive buccal tablet formulations for delivery of nicotine into the oral cavity were developed. Carbomer (Carbopol(R)974P NF) (CP) and alginic acid sodium salt (NaAlg) were used as bioadhesive polymers in combination with hydroxypropyl methylcellulose (HPMC) at different ratios. Magnesium carbonate was incorporated into the formulations as a pH increasing agent. In vitro release and bioadhesion studies were performed on the developed tablets. In the formulations containing CP:HPMC, the NHT released increased with the increasing HPMC concentration whereas a decrease was observed with increasing HPMC concentration in formulations containing NaAlg:HPMC. The bioadhesive properties of the tablets containing NaAlg:HPMC was not affected by the concentration of the NaAlg (P > 0.05) but increased significantly with the increasing CP concentration (P < 0.05). A decrease in pH of the dissolution medium to acidic values was avoided by incorporation of magnesium hydroxide into the formulations. The developed formulations released NHT for 8 h period, and remained intact except for the formulation containing CP:HPMC at 20:80 ratio. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:173 / 178
页数:6
相关论文
共 50 条
  • [1] Development and evaluation of a buccal bioadhesive system for smoking cessation therapy
    Garg, S.
    Kumar, G.
    PHARMAZIE, 2007, 62 (04): : 266 - 272
  • [2] In vitro/in vivo studies on a buccal bioadhesive tablet formulation of carbamazepine
    Ikinci, G
    Çapan, Y
    Senel, S
    Alaaddinoglu, E
    Dalkara, T
    Hincal, AA
    PHARMAZIE, 2000, 55 (10): : 762 - 765
  • [3] Formulation development of Domperidone buccal bioadhesive hydrophilic matrix tablets
    Madgulkar, Ashwini R.
    Bhalekar, Mangesh R.
    Ner, Amruta S.
    Wable, Nitin D.
    ASIAN JOURNAL OF PHARMACEUTICS, 2011, 5 (01) : 21 - 27
  • [4] Development and Evaluation of Buccal Bioadhesive Tablet of an Anti-emetic Agent Ondansetron
    Nisreen Hassan
    R. K. Khar
    Mushir Ali
    Javed Ali
    AAPS PharmSciTech, 2009, 10 : 1085 - 1092
  • [5] Development and Evaluation of Buccal Bioadhesive Tablet of an Anti-emetic Agent Ondansetron
    Hassan, Nisreen
    Khar, R. K.
    Ali, Mushir
    Ali, Javed
    AAPS PHARMSCITECH, 2009, 10 (04): : 1085 - 1092
  • [6] Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation
    Cheng, YH
    Watts, P
    Hinchcliffe, M
    Hotchkiss, R
    Nankervis, R
    Faraj, NF
    Smith, A
    Davis, SS
    Illum, L
    JOURNAL OF CONTROLLED RELEASE, 2002, 79 (1-3) : 243 - 254
  • [7] Development and in vitro/in vivo evaluations of bioadhesive buccal tablets for nicotine replacement therapy
    Ikinci, G
    Senel, S
    Tokgözoglu, L
    Wilson, CG
    Sumnu, M
    PHARMAZIE, 2006, 61 (03): : 203 - 207
  • [8] In vivo evaluation of a bioadhesive buccal tablet formulation of naproxen sodium in postoperative complications of impacted third molars
    Emek-Çiftçi, D
    Senel, S
    Güngör, N
    JOURNAL OF CONTROLLED RELEASE, 2001, 72 (1-3) : 229 - 232
  • [9] NICOTINE AND SMOKING CESSATION
    Coleman, M.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 16 - 16
  • [10] Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy
    Park, CR
    Munday, DL
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) : 215 - 226